Alembic, Aurobindo recall drugs in US market
3 months ago•Economic Times
Alembic aims for US rebound with new launches
3 months ago•Economic Times
Reduce Alembic Pharma; target of Rs 705: ICICI Securities
4 months ago•Moneycontrol
Broker’s call: Alembic Pharma (Buy)
4 months ago•The Hindu Businessline
Alembic Pharma Q1 Results Review - Execution Remains A Key: Dolat Capital
4 months ago•Bloomberg Quint
Stock to buy today: Alembic Pharmaceuticals (₹732.15)
4 months ago•The Hindu Businessline
Alembic receives USFDA nod for Jarod plant
7 months ago•The Hindu Businessline